ClinVar

Description

Variant summary: CDH1 c.1004G>A (p.Arg335Gln) results in a conservative amino acid change located in the Cadherin-like domain (IPR002126) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.5e-05 in 395984 control chromosomes (gnomAD). The observed variant frequency is approximately 1.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in CDH1 causing Hereditary Breast And Ovarian Cancer Syndrome phenotype (2.1e-05), suggesting that the variant may be benign. c.1004G>A has been reported in the literature in individuals affected with breast cancer (e.g., Momozawa_2018, Uyisenga_2020) and at least one individual with ovarian cancer (e.g., Villy_2021) and one with colorectal cancer (e.g., Raskin_2017). These reports do not provide unequivocal conclusions about association of the variant with breast cancer. Co-occurrences with pathogenic variants have been observed in our lab (RAD51C c.706-2A>G and PMS2 c.2186_2187delTC, p.Leu729GlnfsX6), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 12532420, 12414534, 29212164, 30287823, 32959997, 34541275). Nine submitters have reported clinical-significance assessments for this variant to ClinVar after 2014 with conflicting assessments (VUS, n = 8, likely benign, n = 1). Based on the evidence outlined above, the variant was classified as VUS-possibly benign.